Nucleic acid participation in the formation of presenilin-2-gene exon 5-defective splicing variant

Details for Australian Patent Application No. 2002346224 (hide)

International Classifications

Event Publications

6 March 2003 Complete Application Filed

Priority application(s): 2001-195472 27.06.01 JP

15 May 2003 Application Open to Public Inspection

Published as AU-B-2002346224

13 October 2005 Application Accepted

Published as AU-B-2002346224

9 February 2006 Standard Patent Sealed

9 February 2006 Corrigenda

Applications Accepted - Name Index Under the name Taisho Pharmaceutical Co. Ltd.; Japan Science and Technology Agency, Application No. 2002346224, under INID(54) correct the title to read Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant.

14 December 2006 Assignment Registered

Taisho Pharmaceutical Co., Ltd.; Japan Science and Technology Agency The patent has been assigned to Japan Science and Technology Agency

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.